Unresectable Ameloblastoma Successfully Treated with Definitive Proton Therapy.
Journal: 2019/November - International Journal of Particle Therapy
ISSN: 2331-5180
Abstract:
We report the case of an 87-year-old man affected by an unresectable ameloblastoma of the right jaw that was successfully treated by definitive proton therapy up to a dose of 66 Gy in 33 fractions. Treatment was well tolerated, and there were no interruptions due to toxicity. At follow-up visits, the patient experienced complete response to treatment with no evidence of disease and complete recovery from acute side effects. In this report, we discuss the potential and possible pitfalls of proton therapy in the treatment of specific settings.
Relations:
Content
References
(18)
Diseases
(1)
Conditions
(1)
Anatomy
(3)
Similar articles
Articles by the same authors
Discussion board
Int J Part Ther 4(1): 7-13

Unresectable Ameloblastoma Successfully Treated with Definitive Proton Therapy

Proton Therapy Unit, Department of Oncology, Ospedale di Trento, Trento, Italy
Proton Therapy Unit, Department of Medical Physics, Ospedale di Trento, Trento, Italy
Department of Pathology, Ospedale di Trento, Trento, Italy
Department of Radiology Ospedale di Trento, Trento, Italy
Department of Otolaryngology, Ospedale di Trento, Trento, Italy
Corresponding author.
Corresponding author: Francesco Dionisi, Proton Therapy Unit, Department of Oncology, Ospedale di Trento, Trento, Italy, Phone: 0039046111953127, ti.nt.sspa@isinoid.ocsecnarf
Received 2017 Feb 27; Accepted 2017 Jul 6.

Abstract

We report the case of an 87-year-old man affected by an unresectable ameloblastoma of the right jaw that was successfully treated by definitive proton therapy up to a dose of 66 Gy in 33 fractions. Treatment was well tolerated, and there were no interruptions due to toxicity. At follow-up visits, the patient experienced complete response to treatment with no evidence of disease and complete recovery from acute side effects. In this report, we discuss the potential and possible pitfalls of proton therapy in the treatment of specific settings.

Keywords: ameloblastoma, head and neck cancer, paranasal sinus cancer, proton therapy
Abstract

ADDITIONAL INFORMATION AND DECLARATIONS

Conflicts of Interest: The authors have no conflicts to disclose.

ADDITIONAL INFORMATION AND DECLARATIONS

References

  • 1. Lau SL, Samman NRecurrence related to treatment modalities of unicystic ameloblastoma: a systematic review. Int J Oral Maxillofac Surg. 2006;35:681–90.[PubMed]
  • 2. Kennedy WR, Werning JW, Kaye FJ, Mendenhall WMTreatment of ameloblastoma and ameloblastic carcinoma with radiotherapy. Eur Arch Otorhinolaryngol. 2016;273:3293–7.[PubMed]
  • 3. Wilson RRRadiological use of fast protons. Radiology. 1946;47:487–91.[PubMed]
  • 4. Mishra MV, Aggarwal S, Bentzen SM, Knight N, Mehta MP, Regine WFEstablishing evidence-based indications for proton therapy: an overview of current clinical trials. Int J Radiat Oncol Biol Phys. 2017;97:228–35.[PubMed]
  • 5. Langendijk JA, Lambin P, De Ruysscher D, Widder J, Bos M, Verheij MSelection of patients for radiotherapy with protons aiming at reduction of side effects: the model-based approach. Radiother Oncol. 2013;107:267–73.[PubMed]
  • 6. Philip M, Morris CG, Werning JW, Mendenhall WMRadiotherapy in the treatment of ameloblastoma and ameloblastic carcinoma. Hong Kong J Radiol. 2005;8:157–61.[PubMed]
  • 7. Koca T, Basaran H, Arslan D, Sezen D, Cerkesli ZA, Kilinc O, Karaca S, Bassorgun CI, Okay HO, Demirci MProminent response with helical tomotherapy in recurrent ameloblastic carcinoma of maxillary sinus: a case report. Radiat Oncol. 2014;9:157.
  • 8. Mendenhall WM, Werning JW, Fernandes R, Malyapa RS, Mendenhall NPAmeloblastoma. Am J Clin Oncol. 2007;30:645–8.[PubMed]
  • 9. Jensen AD, Ecker S, Ellerbrock M, Nikoghosyan A, Debus J, Munter MWCarbon ion therapy for ameloblastic carcinoma. Radiat Oncol. 2011;6:13.
  • 10. Durante MNew challenges in high-energy particle radiobiology. Br J Radiol. 2014;87:20130626.
  • 11. McDonald MW, Liu Y, Moore MG, Johnstone PAAcute toxicity in comprehensive head and neck radiation for nasopharynx and paranasal sinus cancers: cohort comparison of 3D conformal proton therapy and intensity modulated radiation therapy. Radiat Oncol. 2016;11:32.
  • 12. Ruggieri R, Dionisi F, Mazzola R, Fellin F, Fiorentino A, Schwarz M, Ricchetti F, Amichetti M, Alongi FNasal cavity reirradiation: a challenging case for comparison between proton therapy and volumetric modulated arc therapy. Tumori. 2016;102(suppl 2):12–5.[PubMed]
  • 13. Romesser PB, Cahlon O, Scher E, Zhou Y, Berry SL, Rybkin A, Sine KM, Tang S, Sherman EJ, Wong R, Lee NYProton beam radiation therapy results in significantly reduced toxicity compared with intensity-modulated radiation therapy for head and neck tumors that require ipsilateral radiation. Radiother Oncol. 2016;118:286–92.
  • 14. McDonald MW, Zolali-Meybodi O, Lehnert SJ, Estabrook NC, Liu Y, Cohen-Gadol AA, Moore MGReirradiation of recurrent and second primary head and neck cancer with proton therapy. Int J Radiat Oncol Biol Phys. 2016;96:808–19.[PubMed]
  • 15. Patel SH, Wang Z, Wong WW, Murad MH, Buckey CR, Mohammed K, Alahdab F, Altayar O, Nabhan M, Schild SE, Foote RLCharged particle therapy versus photon therapy for paranasal sinus and nasal cavity malignant diseases: a systematic review and meta-analysis. Lancet Oncol. 2014;15:1027–38.[PubMed]
  • 16. Daly ME, Lau DH, Farwell DG, Luu Q, Donald PJ, Chen AMFeasibility and toxicity of concurrent chemoradiation for elderly patients with head and neck cancer. Am J Otolaryngol. 2013;34:631–5.[PubMed]
  • 17. Fukumitsu N, Ishikawa H, Ohnishi K, Terunuma T, Mizumoto M, Numajiri H, Aihara T, Okumura T, Tsuboi K, Sakae T, Sakurai HDose distribution resulting from changes in aeration of nasal cavity or paranasal sinus cancer in the proton therapy. Radiother Oncol. 2014;113:72–6.[PubMed]
  • 18. Veiga C, Janssens G, Teng CL, Baudier T, Hotoiu L, McClelland JR, Royle G, Lin L, Yin L, Metz J, Solberg TD, Tochner Z, Simone CB, II, McDonough J, Teo BKFirst clinical investigation of cone beam computed tomography and deformable registration for adaptive proton therapy for lung cancer. Int J Radiat Oncol Biol Phys. 2016;95:549–59.[PubMed]
  • 19. Liu W, Frank SJ, Li X, Li Y, Park PC, Dong L, Zhu X, Mohan REffectiveness of robust optimization in intensity-modulated proton therapy planning for head and neck cancers. Med Phys. 2013;40:051711.
Collaboration tool especially designed for Life Science professionals.Drag-and-drop any entity to your messages.